AIMCA
AMRX icon

Alberta Investment Management Corp (AIMCo)’s Amneal Pharmaceuticals AMRX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-131,267
Closed -$407K – 1050
2023
Q2 		$407K Hold
131,267
– – ﹤0.01% 989
2023
Q1 		$182K Hold
131,267
– – ﹤0.01% 1182
2022
Q4 		$261K Buy
+131,267
New +$294K ﹤0.01% 986
2020
Q4 		– Sell
-73,700
Closed -$286K – 854
2020
Q3 		$286K Hold
73,700
– – ﹤0.01% 889
2020
Q2 		$351K Buy
+73,700
New +$303K ﹤0.01% 907

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return